TAIWAN EARNING CO., LTD. was founded in 2014 and specialized in veterinary oncology. Clinical statistics points out cancer tops the cause of mortality in pets. As high as 47% of dogs and one-third of cats above 7-year-old could die on cancer, raising the most concerns and issue of healthcare for pet owners.
EARNING developed advanced veterinary oncology ablation technology. KENAZAGE is a thermoablation device and MITAX is used to image-guided interventional microablation. Both devices are designed to heat target tumor thus cause comprehensive necrosis within the tumor.
